Richard H. Aster

17.9k total citations · 2 hit papers
261 papers, 13.0k citations indexed

About

Richard H. Aster is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Richard H. Aster has authored 261 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Hematology, 91 papers in Surgery and 73 papers in Genetics. Recurrent topics in Richard H. Aster's work include Platelet Disorders and Treatments (180 papers), Blood groups and transfusion (87 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (81 papers). Richard H. Aster is often cited by papers focused on Platelet Disorders and Treatments (180 papers), Blood groups and transfusion (87 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (81 papers). Richard H. Aster collaborates with scholars based in United States, Germany and China. Richard H. Aster's co-authors include James H. Jandl, Daniel W. Bougie, Brian R. Curtis, Gian Paolo Visentin, Peter J. Newman, Thomas J. Kunicki, Janice G. McFarland, G. A. Becker, Rebecca S. Derbes and Brian R. Curtis and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Richard H. Aster

254 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet Sequestration in Man. I. Methods*

1964 735 citations Richard H. Aster et al. Journal of Clinical Investigation profile →
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.

1966 647 citations Richard H. Aster Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Richard H. Aster

Since Specialization

Citations

This map shows the geographic impact of Richard H. Aster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard H. Aster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard H. Aster more than expected).

Fields of papers citing papers by Richard H. Aster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard H. Aster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard H. Aster. The network helps show where Richard H. Aster may publish in the future.

Co-authorship network of co-authors of Richard H. Aster

This figure shows the co-authorship network connecting the top 25 collaborators of Richard H. Aster. A scholar is included among the top collaborators of Richard H. Aster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard H. Aster. Richard H. Aster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	<p>Post-Transfusion Purpura: Current Perspectives</p> 2019 ·Journal of Blood Medicine ·(unknown), Richard H. Aster, Brian R. Curtis	24
2	Drug-Induced Immune Thrombocytopenia (DITP) Caused By Multiple Drug-Dependent Platelet-Reactive Antibodies (DDAbs) in Patients Undergoing Oxaliplatin-Containing Combination Chemotherapy for Metastatic Colon Cancer 2017 ·Blood ·Brian R. Curtis, Yen‐Michael S. Hsu, Nikolai A. Podoltsev, Jill Lacy, Susanna A. Curtis, Robert A. DeSimone, Michael S. Samuel, (unknown), Daniel W. Bougie, Richard H. Aster	0
3	A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies 2017 ·CHEST Journal ·Curtis G. Jones, Shannon M. Pechauer, Brian R. Curtis, Daniel W. Bougie, Mehraboon S. Irani, Binod Dhakal, (unknown), Richard H. Aster, Anand Padmanabhan	17
4	Recommendations for the use of the non‐obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug‐induced thrombocytopenia: communication from the SSC of the ISTH 2015 ·Journal of Thrombosis and Haemostasis ·(unknown), Jens C. Fuhrmann, Beng H. Chong, Daniel W. Bougie, Richard H. Aster	9
5	Structure-Guided Design of a High-Affinity Platelet Integrin α _IIb β ₃ Receptor Antagonist That Disrupts Mg ²⁺ Binding to the MIDAS 2012 ·Science Translational Medicine ·Jieqing Zhu, Won Suk Choi, (unknown), Ana Negri, Jianghai Zhu, (unknown), Jihong Li, Min Shen, Wenwei Huang, Daniel W. Bougie, Mark Rasmussen, Richard H. Aster, Craig J. Thomas, Marta Filizola, Timothy A. Springer, Barry S. Coller	73
6	Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice 2012 ·Blood ·Grace M. Thomas, Carla Carbó, Brian R. Curtis, Kimberly Martinod, Irina B. Mazo, Daphne Schatzberg, Stephen M. Cifuni, Tobias A. Fuchs, Ulrich H. von Andrian, John H. Hartwig, Richard H. Aster, Denisa D. Wagner	252
7	Vancomycin-Induced Immune Thrombocytopenia 2007 ·New England Journal of Medicine ·Annette von Drygalski, Brian R. Curtis, Daniel W. Bougie, Janice G. McFarland, (unknown), (unknown), Kelty R. Baker, Richard H. Aster	151
8	Drug-Induced Immune Thrombocytopenia 2007 ·New England Journal of Medicine ·Richard H. Aster, Daniel W. Bougie	369
9	Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies 2006 ·Blood ·Daniel W. Bougie, Peter R. Wilker, Richard H. Aster	77
10	Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25− (Nonregulatory) T Cells 2005 ·The Journal of Immunology ·Chao Yan Liu, Manuela Battaglia, Seon Ho Lee, Qi‐Hong Sun, Richard H. Aster, Gian Paolo Visentin	105
11	Eptifibatide‐induced acute profound thrombocytopenia presenting as refractory hypotension 2002 ·Catheterization and Cardiovascular Interventions ·Shereif H. Rezkalla, John J. Hayes, Brian R. Curtis, Richard H. Aster	22
12	Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis 2001 ·Journal of Laboratory and Clinical Medicine ·Gian Paolo Visentin, (unknown), (unknown), (unknown), Richard H. Aster	107
13	Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura 1999 ·American Journal of Hematology ·Thomas J. Raife, (unknown), Richard H. Aster, Janice G. McFarland, Jerome L. Gottschall	7
14	Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies 1998 ·Journal of Vascular Surgery ·Robert L. Hewitt, Donald L. Akers, Cindy Leissinger, Javed Gill, Richard H. Aster	17
15	Characterization of the humoral immune response in heparin-induced thrombocytopenia 1997 ·American Journal of Hematology ·Jang Soo Suh, Mohammad Malik, Richard H. Aster, Gian Paolo Visentin	96
16	An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system. 1992 ·Journal of Clinical Investigation ·R Wang, Kenichi Furihata, Janice G. McFarland, Kenneth D. Friedman, Richard H. Aster, Peter J. Newman	67
17	Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. 1988 ·Journal of Clinical Investigation ·Peter J. Newman, Jack Gorski, (unknown), Susan Gidwitz, (unknown), Richard H. Aster	162
18	Posttransfusion purpura associated with alloantibody specific for the platelet antigen, Pen^a 1988 ·American Journal of Hematology ·Toby L. Simon, (unknown), Thomas J. Kunicki, Kenichi Furihata, Kenneth J. Smith, Richard H. Aster	11
19	On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. 1987 ·Journal of Clinical Investigation ·Kenichi Furihata, Diane J. Nugent, (unknown), Richard H. Aster, TJ Kunicki	98
20	Post-Transfusion Purpura 1977 ·Thrombosis and Haemostasis ·Richard H. Aster	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact